Relief Therapeutics Holding AG (RLFTF)

[tcm55]

RLF-100 has been used through the EAP program by hundreds of patients too sick to qualify for most other treatments/Trials. 'Word' is that there are strong results. That Data Has been collected already so future use under COVID EAP programs shouldn't be an issue, at least for RLF-100 and their acquired data.
I believe NRX/RLF are working to present a combination of the data from their EAP program and the COVID Trial results in application(s) for EUA. The EUA and a path for FDA approval for several indications are in the works. I hope...
Go NRLA...GLTA...